Literature DB >> 22000299

Guidelines for the diagnosis and management of hypertrophic cardiomyopathy.

Christopher Semsarian1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22000299     DOI: 10.1016/j.hlc.2011.07.017

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


× No keyword cloud information.
  10 in total

1.  Postnatal ablation of Foxm1 from cardiomyocytes causes late onset cardiac hypertrophy and fibrosis without exacerbating pressure overload-induced cardiac remodeling.

Authors:  Craig Bolte; Yufang Zhang; Allen York; Tanya V Kalin; Jo El J Schultz; Jeffery D Molkentin; Vladimir V Kalinichenko
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

2.  Inpatient detection of cardiac-inherited disease: the impact of improving family history taking.

Authors:  Kathryn E Waddell-Smith; Tom Donoghue; Stephanie Oates; Amanda Graham; Jackie Crawford; Martin K Stiles; Andrew Aitken; Jonathan R Skinner
Journal:  Open Heart       Date:  2016-02-16

3.  Childhood Cardiomyopathies: A Study in Tertiary Care Hospital in Upper Egypt.

Authors:  Mohamed Abd Elaal Bakeet; Montaser Mohamed Mohamed; Ahmed Ahmed Allam; Rania Gamal
Journal:  Electron Physician       Date:  2016-11-25

4.  Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: A case report.

Authors:  Xu Chen; Jun Jiang; Weiliang Zhu; Yuan Wu; Maolong Su
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life.

Authors:  Erica Zaiser; Amy J Sehnert; Ashley Duenas; Sara Saberi; Ella Brookes; Matthew Reaney
Journal:  J Patient Rep Outcomes       Date:  2020-12-01

6.  Development of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ): A New Patient-Reported Outcome (PRO) Instrument.

Authors:  Matthew Reaney; Veleka Allen; Amy J Sehnert; Liang Fang; Albert A Hagège; Srihari S Naidu; Iacopo Olivotto
Journal:  Pharmacoecon Open       Date:  2022-06-02

7.  Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.

Authors:  Matthew Reaney; Prithvi Addepalli; Veleka Allen; John A Spertus; Chantal Dolan; Amy J Sehnert; Jennifer T Fine
Journal:  Pharmacoecon Open       Date:  2022-06-20

8.  Cardiomyopathies in children.

Authors:  Young Mi Hong
Journal:  Korean J Pediatr       Date:  2013-02-25

9.  Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers.

Authors:  Joanna Sweeting; Jodie Ingles; Anna Timperio; Jillian Patterson; Kylie Ball; Christopher Semsarian
Journal:  Open Heart       Date:  2016-07-20

10.  Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results.

Authors:  Yana Smagarinsky; Charlotte Burns; Catherine Spinks; Christopher Semsarian; Jodie Ingles
Journal:  Pilot Feasibility Stud       Date:  2017-11-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.